Proton pump inhibitor induced subacute cutaneous lupus erythematosus: Clinical characteristics and outcomes
暂无分享,去创建一个
[1] V. Werth,et al. Drug-induced subacute cutaneous lupus erythematosus in previously diagnosed systemic lupus erythematosus patients: A case series , 2021, JAAD case reports.
[2] N. Aggarwal. Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Proton Pump Inhibitors , 2016, Drugs - Real World Outcomes.
[3] Jason B. Lee,et al. Widespread Scaly Eruption in a Patient With Multiple Comorbidities. , 2015, JAMA.
[4] R. Hung,et al. Proton pump inhibitor‐induced subcutaneous lupus erythematosus in a patient with systemic lupus erythematosus , 2015, Clinical and experimental dermatology.
[5] G. Ciccarese,et al. Subacute cutaneous lupus erythematosus induced by lansoprazole , 2015, European Journal of Clinical Pharmacology.
[6] R. Laurinaviciene,et al. Proton pump inhibitor-induced subacute cutaneous lupus erythematosus , 2014, The British journal of dermatology.
[7] C. Goulvestre,et al. Subacute Cutaneous Lupus Erythematosus Induced and Exacerbated by Proton Pump Inhibitors , 2013, Dermatology.
[8] A. Reich,et al. Subacute cutaneous lupus erythematosus due to proton pump inhibitor intake: case report and literature review , 2012, Archives of medical science : AMS.
[9] F. Granath,et al. Subacute cutaneous lupus erythematosus and its association with drugs: a population‐based matched case–control study of 234 patients in Sweden , 2012, The British journal of dermatology.
[10] R. Marsden,et al. A difficult diagnosis: drug‐induced subacute cutaneous lupus erythematosus (SCLE) triggered by omeprazole in a patient with pre‐existing idiopathic SCLE , 2012, Clinical and experimental dermatology.
[11] P. J. Olasolo,et al. Esomeprazole-Induced Subacute Cutaneous Lupus Erythematosus , 2011 .
[12] A. Marzano,et al. Drug‐induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart , 2011, The British journal of dermatology.
[13] D. Buckley,et al. Drug‐induced subacute cutaneous lupus erythematosus associated with omeprazole , 2011, Clinical and experimental dermatology.
[14] C. Hansen,et al. A systematic review of drug‐induced subacute cutaneous lupus erythematosus , 2011, The British journal of dermatology.
[15] J. Alcántara-González,et al. [Esomeprazole-induced subacute cutaneous lupus erythematosus]. , 2011, Actas dermo-sifiliograficas.
[16] K. Mckenna,et al. Anti-Ro and anti-La antibody positive subacute cutaneous lupus erythematosus (SCLE) induced by lansoprazole. , 2010, European journal of dermatology : EJD.
[17] N. Burrows,et al. Omeprazole‐induced subacute cutaneous lupus erythematosus , 2010, Clinical and experimental dermatology.
[18] V. Limaye,et al. Diagnostic utility of anti-Ro52 detection in systemic autoimmunity , 2010, Postgraduate Medical Journal.
[19] A. Marzano,et al. Drug-induced lupus: an update on its dermatologic aspects , 2009, Lupus.
[20] M. Pinto,et al. Lansoprazole‐induced subacute cutaneous lupus erythematosus , 2009, Clinical and experimental dermatology.
[21] B. Zimmermann,et al. Drug-Induced Lupus due to Anti-Tumor Necrosis Factor α Agents , 2008 .
[22] M. Wahren-Herlenius,et al. Clinical follow-up of 102 anti-Ro/SSA-positive patients with dermatological manifestations. , 2008, Acta dermato-venereologica.
[23] B. Zimmermann,et al. Drug-induced lupus due to anti-tumor necrosis factor alpha agents. , 2008, Seminars in arthritis and rheumatism.
[24] R. Sontheimer,et al. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation , 2008, Archives of Dermatological Research.
[25] A. Bygum,et al. Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors. , 2008, Acta dermato-venereologica.
[26] T. Nijsten,et al. Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases. , 2005, Acta dermato-venereologica.
[27] T. Luger,et al. Terbinafine-induced subacute cutaneous lupus erythematosus. , 2001, Journal of the American Academy of Dermatology.
[28] T. Yoshimasu,et al. Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT). , 2001, European journal of dermatology : EJD.
[29] P. Orton,et al. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. , 1985, Annals of internal medicine.